Low-dose aspirin mitigates liver cancer risk: Study

Updated:5 years, 7 months ago

New Delhi, Mar 14 (ANI): Among adults at high risk of liver cancer, those who took low-dose aspirin were less likely to develop the disease or to die from liver-related causes. The findings come from an analysis published in the New England Journal of Medicine and conducted by a team led by investigators at the Karolinska Institutet, in Sweden, and Massachusetts General Hospital (MGH). For the analysis, investigators examined information from Swedish registries on 50,275 adults who had chronic viral hepatitis, a type of liver infection that is caused by the hepatitis B or C virus and is the most common risk factor for liver cancer. Over a median follow-up of nearly 8 years, 4.0% of patients who took low-dose aspirin (less than 163mg/day) and 8.3% of nonusers of aspirin developed liver cancer. Aspirin users had a 31% lower relative risk of developing liver cancer. Importantly, the study showed that the longer a person took low-dose aspirin, the greater the benefit. Compared with short-term use (3 months to 1 year), the risk of liver cancer was 10% lower for 1-3 years of use, 34% lower for 3-5 years of use, and 43% lower for 5 or more years of use. Also, liver-related deaths occurred in 11.0% of aspirin users compared with 17.9% of nonusers over 10 years, for a 27% lower risk. The benefits were seen regardless of sex, the severity of hepatitis, or type of hepatitis virus (B or C). The risk of internal bleeding--a concern when taking aspirin long-term--was not significantly elevated among aspirin users.

Top Videos

Updated:4 years, 9 months ago

Pan-India dry run for COVID vaccine tomorrow: Harsh Vardhan

Updated:4 years, 9 months ago

PM Modi joins world leaders in condemning US Capitol siege

Updated:4 years, 10 months ago

Indo-Japan Samvad: Buddha’s message spread out from India to world, says PM Modi

Updated:4 years, 10 months ago

Centre preparing with states for past 4 months for COVID-19 vaccination: Harsh Vardhan

Updated:4 years, 10 months ago

In Jan, India may be in position to give 1st COVID vaccine shot: Harsh Vardhan

Updated:4 years, 10 months ago

Worst is over but still need to be cautious: Health Minister on COVID-19 cases in India

Low-dose aspirin mitigates liver cancer risk: Study

Top Videos

Related Video

Aggressive intervention recommended to prevent pediatric diabetes, finds study

Study reveals high fat diets may over-activate destructive heart disease protein

Consuming diet high in poor quality carbohydrates linked to heart attacks, death risk

Researchers find light activities may help women's mobility during ageing

COVID antibodies are transferred from pregnant women to their babies

Overweight, diabetic people at risk of developing nonalcoholic fatty liver disease

Study reveals factors linked with elevated risk of bone fracture

Damage to heart found in more than half of COVID-19 patients discharged from hospital

LGB people more prone to mental health disorders, alcohol misuse

Unacceptably high levels of carcinogens inhaled by commuters

Post-surgery in kids, aspirin preferred to prevent blood clots

Coffee consumption related with decreased heart failure risk

Study reveals high blood pressure causes atrial fibrillation

Greater retail availability of marijuana, alcohol linked with co-use among teens

COVID-19 patients have higher risk of dying after cardiac arrest

World Cancer Day: Understanding role of nutrition, lifestyle changes to control cancer

Pregnancy complications increase risk of heart disease in women

Antibiotic may improve depressive symptoms in people with low-level inflammation: Study

Serious complications during pregnancy linked to higher risk of death: Study

Study reveals what causes irritable bowel syndrome